Infinity Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance
Infinity Pharmaceuticals, Inc. had Deferred Tax Assets, Valuation Allowance of $256.41 million as of 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2023-03-28
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $256.41M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $244.37M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $230.74M.
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $219.97M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2022-12-31 | $256.41M 10-K · filed 2023-03-28 |
| 2021-12-31 | $244.37M 10-K · filed 2023-03-28 |
| 2020-12-31 | $230.74M 10-K · filed 2022-03-29 |
| 2019-12-31 | $219.97M 10-K · filed 2021-03-16 |
| 2018-12-31 | $207.12M 10-K · filed 2020-03-03 |
| 2017-12-31 | $205.07M 10-K · filed 2019-03-14 |
| 2016-12-31 | $262.79M 10-K · filed 2018-03-15 |
| 2015-12-31 | $252.88M 10-K · filed 2017-03-14 |
| 2014-12-31 | $200.83M 10-K · filed 2016-02-23 |
| 2013-12-31 | $188.81M 10-K · filed 2015-02-24 |
| 2012-12-31 | $129.71M 10-K · filed 2014-02-25 |
| 2011-12-31 | $105.54M 10-K · filed 2013-03-05 |